About this Medicine article
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS) by Morschhauser, Franck; Flinn, Ian W; Advani, Ranjana; Sehn, Laurie H; Diefenbach, Catherine; Kolibaba, Kathryn; Press, Oliver W; Salles, Gilles; Tilly, Hervé; Chen, Andy I; Assouline, Sarit; Cheson, Bruce D; Dreyling, Martin; Hagenbeek, Anton; Zinzani, Pier Luigi; Jones, Surai; Cheng, Ji; Lu, Dan; Penuel, Elicia; Hirata, Jamie; Wenger, Michael; Chu, Yu-Waye; Sharman, Jeff is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Morschhauser, Franck; Flinn, Ian W; Advani, Ranjana; Sehn, Laurie H; Diefenbach, Catherine; Kolibaba, Kathryn; Press, Oliver W; Salles, Gilles; Tilly, Hervé; Chen, Andy I; Assouline, Sarit; Cheson, Bruce D; Dreyling, Martin; Hagenbeek, Anton; Zinzani, Pier Luigi; Jones, Surai; Cheng, Ji; Lu, Dan; Penuel, Elicia; Hirata, Jamie; Wenger, Michael; Chu, Yu-Waye; Sharman, Jeff
- Publisher
- Elsevier ; Elsevier Limited; Elsevier BV (ISSN 2352-3026)
- Published
- 2019
- Field
- Medicine (Health Sciences)